Citizens Upgrades RXO to Market Outperform, Announces $30 Price Target

Benzinga Newsdesk www.benzinga.com Positive 92.5%

Neg 0% Neu 0% Pos 92.5%

Citizens analyst Jeff Kauffman upgrades RXO (NYSE:RXO) from Market Perform to Market Outperform and announces $30 price target.